chartexchange

SRTS
Sensus Healthcare, Inc
stockNASDAQ

At CloseOct 2, 2026 3:57:08 PM EDT
2.99USD+1.356%(+0.04)17,173
Loading…
Loading…
Healthcare
Medical Devices
CEO
Joseph Sardano
HQ
Boca Raton, FL, USA
Previous Close
$2.95
Beta
0.89
52-Week High
$5.49 2026-01-13
52-Week Low
$2.66 2026-06-08
SMA 50
$3.10
SMA 200
$3.67
Avg. Vol 10D
27,168
Avg. Vol 30D
35,475
Avg. Vol 90D
38,049
Relative Vol
0.48
13.55M
0.4700%
1,600,000
Nov 5, 2026 (31d)
SRTS Profile

sensus healthcare, inc. is a medical device company that is committed to enabling non-invasive and cost-effective treatment of non-melanoma skin cancer and keloids. sensus uses a proprietary low energy x-ray radiation technology known as superficial radiation therapy (srt), which is a result of over a decade of dedicated research and development activities. sensus has successfully incorporated the srt therapy into its portfolio of treatment devices: srt-100™ and srt-100 vision™. srt technology effectively and safely treats oncological and non-oncological skin conditions. for more information, visit http://www.sensushealthcare.com.

SRTS Performance
PeriodPriceDateChangeBeta
1W3.002026-09-28+0.17%1.100
1M3.192026-09-04-5.96%0.994
3M3.052026-07-06-1.64%0.711
6M4.232026-04-06-29.08%0.312
1Y3.432025-10-03-12.54%0.886
2Y6.292024-10-04-52.30%—
5Y3.702021-10-04-18.81%0.935
SRTS Stock Summary

Sensus Healthcare, Inc (NASDAQ:SRTS) stock price today is $3.00, and today's volume is 17,173. SRTS is up 1.695% today. The 30 day average volume is 35,475. SRTS market cap is $49.39M with 16.46M shares outstanding.